Search research articles
Contact Us
Filters
Showing results (261-270 of 288) with videos related to
Page
of 29
Sort By:
Kidney International
|
September 4, 2018
HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy
Huai-Yu Wang, Zhao Cui, Li-Jun Xie, et al.
Journal of the American Society of Nephrology : JASN
|
June 16, 2018
Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome
Hanna Debiec, Claire Dossier, Eric Letouzé, et al.
British Journal of Haematology
|
November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study
Laurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
Journal of the American Society of Nephrology : JASN
|
November 18, 2016
MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy
Zhao Cui, Li-Jun Xie, Fang-Jin Chen, et al.
Kidney International
|
June 22, 2021
Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685
Lena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
Rheumatology (Oxford, England)
|
December 13, 2016
A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome
Magali Jasiek, Alexandre Karras, Véronique Le Guern, et al.
Kidney International
|
September 5, 2020
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients
Lena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 27, 2015
CKD and Its Risk Factors among Patients with Cystinuria
Caroline Prot-Bertoye, Saïd Lebbah, Michel Daudon, et al.
Kidney International
|
November 9, 2020
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández-Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, et al.
The New England Journal of Medicine
|
February 18, 2011
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy
Horia C Stanescu, Mauricio Arcos-Burgos, Alan Medlar, et al.
Page
of 29
Search research articles
Search
Showing results (261-270 of 288) with videos related to
Sort By:
Page
of 29
Kidney International
|
September 4, 2018
HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy
Huai-Yu Wang, Zhao Cui, Li-Jun Xie, et al.
Journal of the American Society of Nephrology : JASN
|
June 16, 2018
Transethnic, Genome-Wide Analysis Reveals Immune-Related Risk Alleles and Phenotypic Correlates in Pediatric Steroid-Sensitive Nephrotic Syndrome
Hanna Debiec, Claire Dossier, Eric Letouzé, et al.
British Journal of Haematology
|
November 13, 2023
Low non-relapse mortality and good haematological and renal responses after autologous haematopoietic stem cell transplantation in multiple myeloma patients with renal insufficiency at transplant: A prospective Société Francophone de Greffe de Moelle-Thérapie Cellulaire observational study
Laurent Garderet, Hafida Ouldjeriouat, Mohamed-Amine Bekadja, et al.
Journal of the American Society of Nephrology : JASN
|
November 18, 2016
MHC Class II Risk Alleles and Amino Acid Residues in Idiopathic Membranous Nephropathy
Zhao Cui, Li-Jun Xie, Fang-Jin Chen, et al.
Kidney International
|
June 22, 2021
Corrigendum to Berchtold L, Letouzé E, Alexander MP, et al. HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients. Kidney Int. 2021;99:671-685
Lena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
Rheumatology (Oxford, England)
|
December 13, 2016
A multicentre study of 95 biopsy-proven cases of renal disease in primary Sjögren's syndrome
Magali Jasiek, Alexandre Karras, Véronique Le Guern, et al.
Kidney International
|
September 5, 2020
HLA-D and PLA2R1 risk alleles associate with recurrent primary membranous nephropathy in kidney transplant recipients
Lena Berchtold, Eric Letouzé, Mariam Priya Alexander, et al.
Clinical Journal of the American Society of Nephrology : CJASN
|
February 27, 2015
CKD and Its Risk Factors among Patients with Cystinuria
Caroline Prot-Bertoye, Saïd Lebbah, Michel Daudon, et al.
Kidney International
|
November 9, 2020
The STARMEN trial indicates that alternating treatment with corticosteroids and cyclophosphamide is superior to sequential treatment with tacrolimus and rituximab in primary membranous nephropathy
Gema Fernández-Juárez, Jorge Rojas-Rivera, Anne-Els van de Logt, et al.
The New England Journal of Medicine
|
February 18, 2011
Risk HLA-DQA1 and PLA(2)R1 alleles in idiopathic membranous nephropathy
Horia C Stanescu, Mauricio Arcos-Burgos, Alan Medlar, et al.
Page
of 29